Net Income

With only 5% of consumers trusting influencers, a new industry-backed program offers a seal of approval to bring transparency to the $37B creator market.

With a Red Hat veteran leading its go-to-market, Astronomer is betting that data orchestration is the key to unlocking enterprise AI at scale.

GoldenTree's oversubscribed $3B fund close highlights a major shift as institutional investors seek flexible, high-yield private credit strategies.

A top honor from the American Journal of Nursing for its CourseConnect platform extends Springer Publishing's 14-year winning streak and highlights a new era.

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

Trulieve's new store highlights its dominance in Florida's booming medical cannabis market, a landscape defined by fierce competition and a race for patients.

Auxly Cannabis Group lost its bid for Ayurcann but secured a profitable backup role, showcasing a shrewd strategy in Canada's consolidating cannabis market.

A landmark deal aims to turn a manufacturing hub into a design capital, but can Guangzhou overcome the challenges of its rapid transformation?

The crypto platform evolves from an AI trading specialist to an all-in-one financial ecosystem, integrating payments, incubation, and a new governance token.

China's top pig producer wins a major ESG award by turning waste into wealth, cutting carbon equivalent to 600M trees, and boosting farmer incomes.

Ditching the old OEM model for a 'win-win ecosystem,' Chery bets on shared tech and green manufacturing. A global summit will test this bold new vision.

The market for at-home NAD+ therapy is booming, but as telehealth offers new convenience, it faces a wave of regulatory and safety questions.

Replimune halts a promising cancer therapy and cuts jobs after a stunning FDA rejection, citing a 'failed' system and inconsistent regulatory process.

Allogene Therapeutics faces a make-or-break moment as it prepares to unveil crucial trial data for its 'off-the-shelf' cancer therapy, cema-cel.

Stephan Crétier, who turned a $25k loan into a $14B security empire, will keynote at SWGSB, offering bankers crucial lessons in risk and resilience.

A jury found Abbott's Similac caused a fatal gut disease in premature infants, igniting a legal firestorm over what the formula giant knew and when.

A Chicago jury found Abbott liable for infants' injuries from Similac, adding to a wave of lawsuits over the deadly intestinal disease NEC.

Gensler's Andy Cohen joins the REIT's board, signaling a strategic shift toward design-led development in LA and Honolulu's premium real estate markets.

After sweeping awards, 'The Ebony Canal' takes its powerful message on Black maternal health from Hollywood to a global stage, aiming for systemic change.

With revenue soaring 265%, Primior Holdings' bet on its GAIA blockchain platform is paying off, bridging real estate with the future of digital assets.